Latest Graham Kelly Stories
SYDNEY, May 18, 2015 /PRNewswire/ -- US-Australian drug discovery and development company, Novogen Limited (ASX:NRT; NASDAQ:NVGN), announced today that company CEO, Dr Graham Kelly, will be
SYDNEY, April 2, 2015 /PRNewswire/ -- Novogen Ltd (ASX:NRT NASDAQ:NVGN) today announced it has appointed US-based public relations firm, PCG Advisory (PCG), to drive the Company's investor-awareness
SYDNEY, March 18, 2015 /PRNewswire/ -- Novogen announced on 18(th) March, 2015 that one of its oncology pipeline drug candidates, Anisina (ATM-3507), has achieved a major milestone in its development,
SYDNEY, March 10, 2015 /PRNewswire/ -- Novogen Ltd (ASX: 'NRT'; Nasdaq: 'NVGN') CEO, Dr Graham Kelly, PhD, was interviewed by Sky News', Helen Dalley about the breakthrough brain cancer drug
SYDNEY, Sept. 3, 2014 /PRNewswire/ -- Novogen Ltd.
SYDNEY, Aug. 13, 2014 /PRNewswire/ -- Australia-US biotechnology company, Novogen Ltd.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.